What You Should Know:
- Verily, a precision health technology company, announced a significant expansion of its wastewater surveillance program into the United Kingdom through an exclusive partnership with Bangor University.
- This collaboration will leverage the university’s wastewater-based public health surveillance program capabilities and main testing lab. Bangor University’s wastewater monitoring capabilities are market leading in the U.K. for environmental bio-surveillance and the
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
GI Partners Makes Major Investment in eClinical Solutions
What You Should Know:
- eClinical Solutions LLC, a provider of digital clinical software and services, announced that it has received a majority investment from GI Partners, a private investment firm.
- This investment highlights eClinical Solutions' strong position as a trusted partner for life science organizations of all sizes seeking to accelerate research and advance therapeutic breakthroughs in an increasingly complex trial landscape.
GI Partners' Commitment to
Read More
Sheba Medical, Paradigm Health Partner to Optimize Clinical Trials
What You Should Know:
- Sheba Medical Center, Israel’s largest hospital, and ARC Innovation, the innovation arm of Sheba, has announced a strategic partnership with Paradigm Health to establish a global network for clinical research.
- This collaboration aims to revolutionize the way clinical trials are conducted, making them more accessible, efficient, and patient-centered.
Leveraging AI to Optimize Clinical Trials
The partnership will utilize Paradigm's AI-driven
Read More
Gilead Sciences and Genesis Therapeutics Partner on AI-Driven Drug Discovery
What You Should Know:
- Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.
- The startegic partnership leverages Genesis' cutting-edge AI platform, GEMS, to accelerate drug discovery and development.
A Powerful Collaboration
Genesis Therapeutics' GEMS platform utilizes advanced AI techniques to generate and
Read More
American Cancer Society and Yosemite Award $6M in Research Grants to Innovate Cancer Scientists
What You Should Know:
The American Cancer Society (ACS) and Yosemite, an oncology-focused venture capital firm, announced the selection of research grants through their Yosemite-ACS Award totaling more than $6 million.These inaugural grants will go to scientists from institutions across the country and are poised to make an impact in immuno-oncology as well as the use of Artificial Intelligence (AI) in cancer prevention, detection, treatment, and healthcare
Read More
Kahun Launches AI Agent for Pharma-Focused Knowledge Sharing
What You Should Know:
- Kahun, a pioneer in medical knowledge structuring, has introduced a new AI Agent specifically designed for the pharmaceutical industry.
- The AI Agent aims to bridge the gap between medical knowledge and patient context, providing professionals with reliable and accessible drug-related information.
Addressing the Challenges of Pharma-Related Information
The rapid pace of drug development and research has made it increasingly difficult for
Read More
Abbott Launches OTC Continuous Glucose Monitor, Lingo
What You Should Know:
- Abbott, a global healthcare company, has announced the U.S. availability of Lingo, a continuous glucose monitoring (CGM) system designed for individuals who want to improve their overall health and wellness.
- Lingo is the first CGM available without a prescription designed for individuals who want to improve their overall health and wellness, regardless of whether they have diabetes.
A Powerful Tool for Health Management
Lingo combines a biosensor
Read More
Genetic Leap, Eli Lilly Partner to Advance RNA Genetic Medicine
What You Should Know:
- Genetic Leap, a pioneering AI-native techbio company, has entered into a strategic research collaboration with Eli Lilly and Company.
- The partnership aims to develop innovative genetic medicine therapeutics using Genetic Leap's cutting-edge RNA-targeted AI platform.
Leveraging AI to Revolutionize RNA Drug Discovery
RNA genetic medicine holds immense promise for addressing a wide range of diseases. By targeting RNA, scientists can potentially
Read More
A Roadmap For Improving Diversity in Cancer Research and Advancing Therapeutic Development
Last month was Cancer Research Awareness Month, which is a great time to celebrate recent findings that the number of adults enrolled in oncology clinical trials has increased – nearly twice as high as past estimates – while also reflecting on the fact that we still have much work to do in overall and proportional clinical trial enrollment. Highlighting the work that still needs to be done, a recent analysis revealed that individuals who participated in new drug trials were not representative of
Read More
FCS Partners with Paradigm to Expand Clinical Trial Access
What You Should Know:
- Florida Cancer Specialists & Research Institute (FCS), a leading provider of comprehensive cancer care, has announced a new partnership with Paradigm Health, a technology platform specializing in clinical trial management.
- The collaboration aims to expand patient access to innovative treatments through more efficient clinical trial recruitment and execution.
A Strategic Partnership for Enhanced Clinical Trial Access
FCS has experienced steady
Read More
